{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:09:57Z","timestamp":1791173397250,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["40420"],"award-info":[{"award-number":["40420"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI095690"],"award-info":[{"award-number":["R01-AI095690"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007810","name":"University of North Carolina Wilmington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1053\/j.gastro.2014.04.021","type":"journal-article","created":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T03:03:07Z","timestamp":1398135787000},"page":"453-462.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Kinetic Analyses Reveal Potent and Early Blockade of Hepatitis C Virus Assembly by NS5A Inhibitors"],"prefix":"10.1053","volume":"147","author":[{"given":"David R.","family":"McGivern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Williford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ingravallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongdi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Lahser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Asante-Appiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Neddermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"De Francesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita Y.","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley M.","family":"Lemon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2014.04.021_bib1","first-page":"4","article-title":"Emerging therapies for the treatment of hepatitis C","volume":"1","author":"Lange","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1053\/j.gastro.2014.04.021_bib2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nrgastro.2011.49","article-title":"A\u00a0new standard of care for the treatment of chronic HCV infection","volume":"8","author":"Hofmann","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2014.04.021_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature08960","article-title":"Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect","volume":"465","author":"Gao","year":"2010","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2014.04.021_bib4","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.bmcl.2009.01.066","article-title":"Synthesis and SAR of piperazinyl-N-phenylbenzamides as inhibitors of hepatitis C virus RNA replication in cell culture","volume":"19","author":"Conte","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1053\/j.gastro.2014.04.021_bib5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1128\/JVI.01360-09","article-title":"Identification of hepatitis C virus NS5A inhibitors","volume":"84","author":"Lemm","year":"2010","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2014.04.021_bib6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.virol.2013.06.032","article-title":"Characterizations of HCV NS5A replication complex inhibitors","volume":"444","author":"O'Boyle Ii","year":"2013","journal-title":"Virology"},{"key":"10.1053\/j.gastro.2014.04.021_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1099\/vir.0.015305-0","article-title":"Hepatitis C virus NS5A protein interacts with beta-catenin and stimulates its transcriptional activity in a phosphoinositide-3 kinase-dependent fashion","volume":"91","author":"Milward","year":"2010","journal-title":"J\u00a0Gen Virol"},{"key":"10.1053\/j.gastro.2014.04.021_bib8","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1128\/JVI.02154-12","article-title":"A\u00a0hepatitis C virus NS5A phosphorylation site that regulates RNA replication","volume":"87","author":"Lemay","year":"2013","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2014.04.021_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jhep.2012.08.007","article-title":"HCV NS5A and IRF9 compete for CypA binding","volume":"58","author":"Bobardt","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2014.04.021_bib10","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/ncb1631","article-title":"The lipid droplet is an important organelle for hepatitis C virus production","volume":"9","author":"Miyanari","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1053\/j.gastro.2014.04.021_bib11","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1021\/jm401499g","article-title":"The discovery of ledipasvir (GS-5885), a potent once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infection","volume":"57","author":"Link","year":"2013","journal-title":"J\u00a0Med Chem"},{"key":"10.1053\/j.gastro.2014.04.021_bib12","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/cmdc.201300343","article-title":"Discovery of MK-8742: an HCV NS5A inhibitor with broad genotype activity","volume":"8","author":"Coburn","year":"2013","journal-title":"Chem Med Chem"},{"key":"10.1053\/j.gastro.2014.04.021_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJMoa1104430","article-title":"Preliminary study of two antiviral agents for hepatitis C genotype 1","volume":"366","author":"Lok","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2014.04.021_bib14","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/hep.26388","article-title":"Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir","volume":"58","author":"McPhee","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2014.04.021_bib15","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1073\/pnas.1203110110","article-title":"Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life","volume":"110","author":"Guedj","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2014.04.021_bib16","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.gastro.2010.10.056","article-title":"Protease inhibitor-resistant hepatitis C virus mutants with reduced fitness from impaired production of infectious virus","volume":"140","author":"Shimakami","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2014.04.021_bib17","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.1128\/JVI.00280-11","article-title":"Hepatitis C virus infection causes cell cycle arrest at the level of initiation of mitosis","volume":"85","author":"Kannan","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2014.04.021_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jhep.2011.12.029","article-title":"A\u00a0phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C","volume":"57","author":"Lawitz","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2014.04.021_bib19","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1128\/AAC.50.3.1013-1020.2006","article-title":"SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon\u00a0cells","volume":"50","author":"Malcolm","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.gastro.2014.04.021_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1128\/AAC.00677-09","article-title":"MK-7009, a potent and selective inhibitor of hepatitis C virus NS3\/4A protease","volume":"54","author":"Liverton","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.gastro.2014.04.021_bib21","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/AAC.01032-08","article-title":"Robust antiviral efficacy upon administration of a nucleoside analog to hepatitis C virus-infected chimpanzees","volume":"53","author":"Carroll","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.gastro.2014.04.021_bib22","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1128\/AAC.00238-08","article-title":"Molecular mechanism of hepatitis C virus replicon variants with reduced susceptibility to a benzofuran inhibitor, HCV-796","volume":"52","author":"Howe","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.gastro.2014.04.021_bib23","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1128\/JVI.00215-11","article-title":"Small molecules targeting hepatitis C virus-encoded NS5A cause subcellular redistribution of their target: insights into compound modes of action","volume":"85","author":"Targett-Adams","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2014.04.021_bib24","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1128\/AAC.00556-10","article-title":"Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in\u00a0vitro replicon system","volume":"54","author":"Fridell","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.gastro.2014.04.021_bib25","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/hep.24594","article-title":"Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in humans: in\u00a0vitro and in\u00a0vivo correlations","volume":"54","author":"Fridell","year":"2011","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2014.04.021_bib26","doi-asserted-by":"crossref","first-page":"e1000032","DOI":"10.1371\/journal.ppat.1000032","article-title":"Regulation of hepatitis C virion production via phosphorylation of the NS5A protein","volume":"4","author":"Tellinghuisen","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1053\/j.gastro.2014.04.021_bib27","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1128\/JVI.02156-10","article-title":"Regulation of the production of infectious genotype 1a hepatitis C virus by NS5A domain III","volume":"85","author":"Kim","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2014.04.021_bib28","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1099\/vir.0.034801-0","article-title":"The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localization","volume":"92","author":"Qiu","year":"2011","journal-title":"J\u00a0Gen Virol"},{"key":"10.1053\/j.gastro.2014.04.021_bib29","doi-asserted-by":"crossref","first-page":"e1003359","DOI":"10.1371\/journal.ppat.1003359","article-title":"The lipid kinase phosphatidylinositol-4 kinase III alpha regulates the phosphorylation status of hepatitis C virus NS5A","volume":"9","author":"Reiss","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1053\/j.gastro.2014.04.021_bib30","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1021\/jm400781h","article-title":"Discovery of selective small molecule type III phosphatidylinositol 4-kinase alpha (PI4KIIIalpha) inhibitors as anti hepatitis C (HCV) agents","volume":"57","author":"Leivers","year":"2013","journal-title":"J\u00a0Med Chem"},{"key":"10.1053\/j.gastro.2014.04.021_bib31","doi-asserted-by":"crossref","first-page":"e1000035","DOI":"10.1371\/journal.ppat.1000035","article-title":"Essential role of domain III of nonstructural protein 5A for hepatitis C virus\u00a0infectious particle assembly","volume":"4","author":"Appel","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1053\/j.gastro.2014.04.021_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2011.03.026","article-title":"The hepatitis C virus NS5A inhibitor (BMS-790052) alters the subcellular localization of the NS5A non-structural viral protein","volume":"414","author":"Lee","year":"2011","journal-title":"Virology"},{"key":"10.1053\/j.gastro.2014.04.021_bib33","doi-asserted-by":"crossref","first-page":"10519","DOI":"10.1128\/JVI.00640-08","article-title":"A\u00a0dynamic view of hepatitis C virus replication complexes","volume":"82","author":"Wolk","year":"2008","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2014.04.021_bib34","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1073\/pnas.0902693106","article-title":"Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication","volume":"106","author":"Berger","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2014.04.021_bib35","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.1128\/JVI.00059-11","article-title":"Hepatitis C virus stimulates the phosphatidylinositol 4-kinase III alpha-dependent phosphatidylinositol 4-phosphate production that is essential for its replication","volume":"85","author":"Berger","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2014.04.021_bib36","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.1128\/JVI.00724-08","article-title":"NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly","volume":"82","author":"Ma","year":"2008","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2014.04.021_bib38","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.gastro.2010.10.056","article-title":"Protease inhibitor-resistant hepatitis C virus mutants with reduced fitness from impaired production of infectious virus","volume":"140","author":"Shimakami","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2014.04.021_bib39","doi-asserted-by":"crossref","first-page":"11074","DOI":"10.1128\/JVI.01150-06","article-title":"Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles","volume":"80","author":"Gastaminza","year":"2006","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2014.04.021_bib40","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1128\/AAC.50.3.1013-1020.2006","article-title":"SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells","volume":"50","author":"Malcolm","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.gastro.2014.04.021_bib41","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1073\/pnas.1112263109","article-title":"Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex","volume":"109","author":"Shimakami","year":"2012","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508514005472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508514005472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:42:39Z","timestamp":1762162959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508514005472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0016508514005472"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2014.04.021","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kinetic Analyses Reveal Potent and Early Blockade of Hepatitis C Virus Assembly by NS5A Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2014.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}